We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential enable/disable

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name	Webedition CMS
Purpose	This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name	econda
Purpose	Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

Statistics enable/disable

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name	econda
Purpose	Statistics

External media enable/disable

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name	YouTube
Purpose	Show YouTube content
Name	Twitter
Purpose	activate Twitter Feeds

Research

Cooperational Research Program

of the Foundation Deutsches Krebsforschungszentrum, Heidelberg, with the Ministry of Science and Technology, Israel

of the Foundation Deutsches Krebsforschungszentrum, Heidelberg, with the Ministry of Science and Technology, Israel

In 1976 the agreement for a cooperational program in cancer research was signed by the Deutsches Krebsforschungszentrum (DKFZ) and, the Israeli National Council for Research and Development (NCRD) – now the Ministry of Science and Technology.

Each of the cooperational joint projects consists of one Israeli and one DKFZ subproject, lasting for a period of three years. Usually 18 joint projects are in operation. The cooperation program is jointly administered by program coordinators from MOST and the DKFZ, and is governed by a scientific program committee composed of experts in the cancer field from Europe and Israel.

(v.l.n.r.) Prof. Dr. Michael Boutros, Scientific Director (interim) DKFZ, Ofir Akunis, Minister of Science and Technology, Israel, Prof. Dr. Dr. h.c. Otmar D. Wiestler, President of the Helmholtz-Gemeinschaft, Prof. Dr. Josef Puchta, Administrative Director DKFZ.
© dkfz.de

In March 2016, a symposium was held celebrating the 40th anniversary of the cooperation in Tel Aviv.

From its very beginnings, the cooperation program saw many renowned scientists taking part as principal investigators. One of them, Aaron Ciechanover, has received the Nobel Prize for Chemistry in October 2004, together with Avram Hershko and Irwin Rose. In the early 1980s, these scientists discovered how the human body disposes of proteins that are no longer needed. The molecule ubiquitin plays a key role in this process. From 1998 – 2000, Aaron Ciechanover and Martin Scheffner from the German Cancer Research Center had a joined project entitled: Regulation of cell regulatory proteins by the ubiquitin-dependent proteolytic pathway. This project, among others, was considered an outstanding project, so-called Highlight-Project.